Herbs

Pura Naturals and Freedom Leaf Reach Strategic Alliance Agreement for CBD Health and Beauty Products

Retrieved on: 
Thursday, January 3, 2019

LAKE FOREST, Calif. and LAS VEGAS, Jan. 3, 2019 /PRNewswire/ --Pura Naturals, Inc. (OTC-PINK:PNAT) ("Pura"), makers of eco-friendly earth-conscious health and beauty products, and Freedom Leaf, Inc. (OTCQB:FRLF) ("Freedom Leaf"), parent company of leading CBD health and wellness brands Leafceuticals, IrieCBD and Hempology, today jointly announced a Strategic Alliance Agreement between the companies.

Key Points: 
  • LAKE FOREST, Calif. and LAS VEGAS, Jan. 3, 2019 /PRNewswire/ --Pura Naturals, Inc. (OTC-PINK:PNAT) ("Pura"), makers of eco-friendly earth-conscious health and beauty products, and Freedom Leaf, Inc. (OTCQB:FRLF) ("Freedom Leaf"), parent company of leading CBD health and wellness brands Leafceuticals, IrieCBD and Hempology, today jointly announced a Strategic Alliance Agreement between the companies.
  • On December 20, 2018, Pura and Freedom Leaf entered into a Strategic Alliance Agreement where Freedom Leaf will supply CBD to Pura as part of Pura's health and beauty line of products that contain CBD.The Pura Health and Beauty Line will feature "IrieCBD Inside" with Freedom Leaf, Inc. receiving a royalty.
  • and Member of the Board of Directors of Freedom Leaf, adds, "Freedom Leaf is happy to provide our CO2 extracted CBD to Pura Naturals for inclusion in their new health and beauty line of products.
  • The company is launching a THC-free line of Hemp CBD health products under the NatureBorn brand, and developing performance CBD beverage and CBD beauty product lines.

Medicinal Genomics Partners with Eiken Chemical for Cannabis Testing to Drive Higher Yield, Ag Productivity

Retrieved on: 
Thursday, January 3, 2019

WOBURN, Mass., Jan. 3, 2019 /PRNewswire/ --Medicinal Genomics Corp. (MGC), a pioneer in improving the quality, quantity and safety of cannabis, today announced it has signed a licensing agreement with Eiken Chemical Co., Ltd. of Tokyo, Japan.

Key Points: 
  • WOBURN, Mass., Jan. 3, 2019 /PRNewswire/ --Medicinal Genomics Corp. (MGC), a pioneer in improving the quality, quantity and safety of cannabis, today announced it has signed a licensing agreement with Eiken Chemical Co., Ltd. of Tokyo, Japan.
  • MGC will integrate the technology in its youPCRproprietary cannabis testing platform for the detection of cannabis genes, genotypes, microorganisms, pests and pathogens on or in cannabis.
  • "We are honored to be able to partner with Eiken and bring its innovative LAMP technology to the cannabis industry," said Medicinal Genomics's Chief Scientific Officer, Kevin McKernan.
  • Medicinal Genomics Corporation has pioneered the genomics of cannabis to build a stronger scientific foundation for cannabis-based products.

Lifestyle Delivery Systems Inc. Announces Temporary Nursery and Cultivation Licenses Issued to Core Isogenics Inc.

Retrieved on: 
Thursday, January 3, 2019

The Nursery will utilize the seeds grown based on the Core Isogenics process.

Key Points: 
  • The Nursery will utilize the seeds grown based on the Core Isogenics process.
  • Lifestyle Delivery Systems Inc.'s CEO, Brad Eckenweiler, stated, "These licenses complete our business model foundation.
  • Developing isogenic seed strains and automated cultivation methods for the cannabis industry with Lifestyle Delivery Systems Inc. a British Columbia company.
  • About Lifestyle Delivery Systems Inc.
    Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California.

Ion Labs Officially Begins Hemp & CBD Manufacturing in 2019

Retrieved on: 
Tuesday, January 1, 2019

Section 7125 also allows the development of industrial hemp and the development of new and emerging commercial products derived from hemp.

Key Points: 
  • Section 7125 also allows the development of industrial hemp and the development of new and emerging commercial products derived from hemp.
  • Ion Labs has announced that they will now begin Hemp & CBD manufacturing in 2019 and plan to incorporate a large range of these products into the operation.
  • Ion Labs plans to focus on manufacturing Hemp and CBD ingestibles and topical products.
  • Businesses that would like to start discussing Hemp and CBD manufacturing capabilities with Ion Labs can inquire through the Ion Labs website, or call 727-527-1072.

Digipath, Inc. Announces Record Results for the Fiscal Year Ended September 30, 2018

Retrieved on: 
Friday, December 28, 2018

LAS VEGAS, Dec. 28, 2018 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory, data acquisition and media firm focused on the developing cannabis market, today announced financial and operating results for the fiscal year ended September30, 2018.

Key Points: 
  • LAS VEGAS, Dec. 28, 2018 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory, data acquisition and media firm focused on the developing cannabis market, today announced financial and operating results for the fiscal year ended September30, 2018.
  • We saw increased revenue due to the continued growth of recreational cannabis, and subsequently received ISO-17025:2017 accreditation in December.
  • We look forward to further growth in the coming year as both the medical and recreational markets continue to grow, along with the recent addition of testing for hemp and CBD producers.
  • The table below shows the preliminary results and key metrics:

TerrAscend Enters US Hemp-Derived Products Market

Retrieved on: 
Monday, December 24, 2018

Their whole-plant hemp extract products are made in the USA and are available for sale in ~10,000 retail locations worldwide.

Key Points: 
  • Their whole-plant hemp extract products are made in the USA and are available for sale in ~10,000 retail locations worldwide.
  • "The collaboration of talent and expertise across the combined organization will give TerrAscend a significant competitive advantage in developing, marketing, and supplying the most cutting-edge products in the hemp-derived cannabinoid market," concluded Frohman.
  • TerrAscend is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market.
  • TerrAscend participates in the legal adult-use market in Canada through direct and indirect supply agreements in several provinces and intends to expand into the US market in states where cannabinoids have been legalized for therapeutic or adult-use.

Farm Bill Plows Fields of Opportunity for CBD, Farmers, Environment

Retrieved on: 
Friday, December 21, 2018

"We look forward to working with all industry stakeholders to help make sure this miraculous plant's manifold benefits are allowed to firmly root, and fully flower."

Key Points: 
  • "We look forward to working with all industry stakeholders to help make sure this miraculous plant's manifold benefits are allowed to firmly root, and fully flower."
  • Meanwhile, China has become the world's leading supplier of cannabis, with most of it being THC-free hemp.
  • It needs little water, grows in poor soil, aerates fields and offers myriad green solutions to existing problems, including excessive plastic, destruction of forests, and mining.
  • "While it remains nascent, it also is positively explosive with energy and opportunity.

Green Growth Brands Recognizes Monumental Policy Shift With Passage of 2018 Farm Bill

Retrieved on: 
Friday, December 21, 2018

COLUMBUS, OH, Dec. 21, 2018 /PRNewswire/ -Green Growth Brands (CSE: GGB OTCQB:GGBXF) (GGB or the Company)recognizes the monumental shift in policy brought about by President Donald Trump's signing of the 2018 Farm Bill yesterday.

Key Points: 
  • COLUMBUS, OH, Dec. 21, 2018 /PRNewswire/ -Green Growth Brands (CSE: GGB OTCQB:GGBXF) (GGB or the Company)recognizes the monumental shift in policy brought about by President Donald Trump's signing of the 2018 Farm Bill yesterday.
  • The Farm Bill's passage comes at a time when Green Growth Brands is set to market and sell hemp-derived CBD personal care products under its Seventh Sense brand.
  • "The new bill is a significant step in America's acceptance of CBD and the benefits it can provide consumers," said Peter Horvath, CEO of Green Growth Brands.
  • Green Growth brands expects to dominate the cannabis and CBD market with a portfolio of emotion-driven brands that people love.

LeafyWell a Subsidiary of PYTG Is Set to Capitalize on the Emerging Interstate Commerce Market Resulting from the Land Mark 2018 US Hemp Farm Bill

Retrieved on: 
Friday, December 21, 2018

The U.S. Senate voted overwhelmingly (87 to 13) to approve the bill.

Key Points: 
  • The U.S. Senate voted overwhelmingly (87 to 13) to approve the bill.
  • The redefinition of hemp opens a whole new realm of opportunity.
  • Hence, its qualified for new and better research, the formulation of premium quality products has the potential to contribute substantially to the economy by benefiting from a legalized interstate CBD and hemp market.
  • Nationwide hemp production will commence imminently, along with interstate commerce, enabling the emergence of what could be an exponentially strengthened industry.

Medical Marijuana, Inc. Celebrates End of 80-Year Ban on Domestic Hemp Crop With Passage of 2018 U.S. Farm Bill

Retrieved on: 
Friday, December 21, 2018

"Today history was made with the passage of the 2018 Farm Bill making hemp a fully legal agricultural crop.

Key Points: 
  • "Today history was made with the passage of the 2018 Farm Bill making hemp a fully legal agricultural crop.
  • It alsomakes the national banking system (a gray area in the cannabis industry) accessible to farmers and others involved.
  • "With the passage of this legislation, we are empowered to now consider domestic sources of hemp as well as potentially participate in over 50,000 industrial uses that the hemp plant offers."
  • These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.